Clin2
NCT07886203Likely a fitRecruiting

Light device for checking vulvar lesions

Vulvar Intraepithelial Neoplasia, HPV-IndependentVulvar Squamous Cell CarcinomaVulvar Squamous Intraepithelial Lesion, HPV-Associated

This study tests a new AI-powered handheld device that shines light on suspicious vulvar lesions to help doctors quickly tell if they might be cancer. If you qualify, the device will be used on your lesion before your surgery, which could lead to faster and more accurate diagnosis in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 years or older.
  • You must have one of these diagnoses: vulvar squamous cell carcinoma, HPV-associated VIN 3, or differentiated VIN.
  • You must be planning surgical removal of the lesion at Mayo Clinic in Rochester.
  • You cannot be pregnant.
  • The lesion must not be too close to the vaginal opening, urethra, or anus, and must not be covered with heavy crust or open sores.
  • You must not have had prior laser, freezing, or radiation treatment at the exact site.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Hear when a new Vulvar Squamous Cell Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.